HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations.

AbstractBACKGROUND AND OBJECTIVES:
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare, autosomal recessive disorder induced by mutations of the gene coding for thrombopoietin (TPO) receptor (c-MPL). Patients initially present with isolated thrombocytopenia that subsequently progresses into pancytopenia. Although the mechanisms leading to aplasia are unknown, the age of onset has been reported to depend on the severity of the c-MPL functional defect. To improve our knowledge in this field, we studied clinical and biological features of five new patients.
DESIGN AND METHODS:
We diagnosed five CAMT patients, identified c-MPL mutations, including five novel alterations and investigated relationships between mutations and their clinical-biological consequences.
RESULTS:
In all cases, platelet c-MPL and bone marrow colonies were reduced, while serum TPO levels were elevated. We also documented that the percentage of bone marrow cells expressing tumor necrosis factor-a and interferon-g was increased during pancytopenia as compared to in controls, suggesting that, as in other bone marrow failure diseases, these inhibitory cytokines contributed to the pancytopenia. Contrary to previously published data, we found no evidence of correlations between different types of mutations and the clinical course.
INTERPRETATION AND CONCLUSIONS:
These results suggest that therapies, such as hematopoietic stem cell transplantation, which are potentially curative although associated with a risk of treatment-related mortality, should not be postponed even in those CAMT patients whose c-MPL mutations might predict residual activity of the TPO receptor.
AuthorsAnna Savoia, Carlo Dufour, Franco Locatelli, Patrizia Noris, Chiara Ambaglio, Vittorio Rosti, Marco Zecca, Simona Ferrari, Filomena di Bari, Anna Corcione, Mariateresa Di Stazio, Marco Seri, Carlo L Balduini
JournalHaematologica (Haematologica) Vol. 92 Issue 9 Pg. 1186-93 (Sep 2007) ISSN: 1592-8721 [Electronic] Italy
PMID17666371 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, Thrombopoietin
  • MPL protein, human
  • Thrombopoietin
Topics
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Blood Platelets (metabolism)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Megakaryocytes (pathology)
  • Molecular Sequence Data
  • Mutation (genetics)
  • Receptors, Thrombopoietin (genetics)
  • Sequence Homology, Amino Acid
  • Thrombocytopenia (congenital, genetics, pathology)
  • Thrombopoietin (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: